Lisette Stork‐Sloots

Genomic Classifier ColoPrint Predicts Recurrence in Stage II Colorectal Cancer Patients More Accurately Than Clinical Factors

Scott Kopetz, Josep Tabernero, Robert Rosenberg et al. · The Oncologist · 2015 · 132 citations · Full text

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

Pat W. Whitworth, Lisette Stork‐Sloots, Femke A. de Snoo et al. · Annals of Surgical Oncology · 2014 · 88 citations · Full text

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping

Pat W. Whitworth, Peter D. Beitsch, Angela Mislowsky et al. · Annals of Surgical Oncology · 2016 · 82 citations · Full text

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial

Giulia Viale, Leen Slaets, Jan Bogaerts et al. · Annals of Oncology · 2014 · 65 citations · Full text

Microarray Readout, Genetic Analysis, Functional Genomics +11

Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients

Bichlien Nguyen, P. Cusumano, Kenneth Deck et al. · Annals of Surgical Oncology · 2012 · 45 citations

Breast Oncology, Cancer Detection, Local Clinical Subtyping +9